Virtual Reality Relaxation Exercises to Improve Well-Being, Quality of Life, and Satisfaction Among Inpatient Cancer Patients Undergoing Chemotherapy
- Gender
- Women and men
- Age
- 18 years and older
- Trial type
- Observational
- Line of therapy
- Relapsed / refractory
- Phase
- —
What is this trial about?
During inpatient chemotherapy, many patients experience stress, anxiety, sleep problems, and physical strain. Virtual reality (VR) offers new ways to facilitate relaxation exercises in an immersive and calming manner. The goal of this study is to determine whether relaxation exercises using virtual reality can be integrated into inpatient treatment. A follow-up study will then test whether these exercises can improve patients’ well-being, quality of life, and satisfaction during their hospital stay. Patients aged 18 and older who are receiving inpatient chemotherapy for lung cancer or acute leukemia (AML or ALL) are eligible to participate.
Trial flow
Requirements
Diagnosis: Lung cancer or acute leukemia (AML or ALL)
Age: 18–75 years
Line of therapy: Unabhängig von Therapielinie
Key inclusion criteria: in-hospital chemotherapy
Allocation
Randomisierung
Treatment
Follow-up
Diagnosis: Lung cancer or acute leukemia (AML or ALL)
Age: 18–75 years
Line of therapy: Unabhängig von Therapielinie
Key inclusion criteria: in-hospital chemotherapy
Randomisierung
Detailed description
This pilot study investigates whether meditative exercises in virtual reality (VR) have a positive effect on emotional well-being, sleep quality, perceived stress, and overall quality of life. During their hospital stay, patients will participate in two daily sessions (one in the morning and one in the evening) using VR headsets in combination with breathing and relaxation exercises. The morning session lasts about 7–8 minutes, and the evening session about 10 minutes, but can be extended at the patients’ request. Vital signs (heart rate, respiration, and blood pressure) are measured before and after the exercises. All patients receive a questionnaire upon admission, on the 7th day, and upon discharge.
The aim of this study is not only to determine whether relaxation exercises using virtual reality (VR) can positively influence the well-being of cancer patients, but above all to assess whether such a program can be effectively implemented in everyday hospital practice. In particular, the study will examine how well patients respond to the exercises and whether they can be easily integrated into the hospital routine. Since this is a so-called pilot study, the focus is not on providing definitive proof of efficacy. Rather, the study aims to determine whether the concept works and is suitable for a larger follow-up study. If the procedures prove to be practical and beneficial, a more comprehensive study could follow in the future, which would then specifically examine whether VR relaxation exercises contribute to improving quality of life in the long term. For this study, patients will be randomly assigned to two groups: One group will receive the VR-based exercises alongside chemotherapy, while the other will serve as a control group without any additional intervention.
Adults between the ages of 18 and 75 with lung cancer or acute leukemia (AML or ALL) are eligible to participate, provided they are receiving inpatient chemotherapy. Excluded are, among others, patients with pre-existing neurological conditions (e.g., epilepsy, psychosis, dementia), severe alcohol or drug dependence, a pacemaker, or insufficient knowledge of German or English.
Facts
- What condition: Lung cancer or acute leukemia (AML or ALL)
- Cancer characteristics: Planned inpatient chemotherapy
- What the study investigates: The effect of VR-assisted relaxation exercises on improving quality of life during hospitalization; Feasibility and willingness to participate in VR exercises
- Study objective: To investigate the feasibility and impact of VR exercises on patients’ well-being and satisfaction during inpatient chemotherapy
- How long does the study last: Daily VR sessions during the hospital stay (morning and evening, Monday through Friday)
- Study characteristics: 2 study groups, randomized, evaluation via questionnaires (3 questionnaires—upon admission, on the 7th day of treatment, and upon discharge)
Trial sites
1 trial site in Germany is listed.
Universitätsklinikum Augsburg
Stenglinstraße 2, 86156 Augsburg
Active, not recruiting
This list is compiled to the best of our knowledge but without guarantee: it may be incomplete, and a site's recruitment status can change at any time.
- Dr. med. Sebastian SommerSpecialist in internal medicine with a focus on hematology and oncology
- PD Dr. med. Matthias FröhlichSpecialist in internal medicine, immunology and emergency medicine
This description was translated into plain language by our medical editorial team. Whether participation is an option for you is a decision you make together with your treating physician.


